Clinomics Inc. (KOSDAQ:352770)
South Korea flag South Korea · Delayed Price · Currency is KRW
490.00
+1.00 (0.20%)
At close: Apr 1, 2025, 3:30 PM KST

Clinomics Revenue

Clinomics had revenue of 1.16B KRW in the quarter ending September 30, 2024, a decrease of -56.54%. This brings the company's revenue in the last twelve months to 8.25B, down -43.51% year-over-year. In the year 2023, Clinomics had annual revenue of 11.41B, down -50.58%.

Revenue (ttm)
8.25B
Revenue Growth
-43.51%
P/S Ratio
2.01
Revenue / Employee
112.96M
Employees
73
Market Cap
18.84B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.41B-11.68B-50.58%
Dec 31, 202223.08B-32.34B-58.35%
Dec 31, 202155.43B45.61B464.42%
Dec 31, 20209.82B5.72B139.45%
Dec 31, 20194.10B2.05B99.71%
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 175.23T
Kia Corporation 107.45T
Celltrion 3,557.30B
KB Financial Group 15.01T
Revenue Rankings